NCT06886711

Research on the Role of Probiotics in Human Intestinal Health

A Study on the Safety and Efectiveness of Bifidobacterium Bifidum BBi32 in Improving Lntestinal and Lmmune Functions

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 45 (estimated)
• Sponsor: Wecare Probiotics Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

Evaluate the efectiveness and safety of Bifidobacterium bifidum BBi32 as a food supplement compared to a placebo in improving intestinal andimmune functions in healthy adults.

Conditions

• Intestinal Microbiota

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Probiotic	Dietary supplement: Probiotics. The trial period of this study lasts for 2 months(8weeks), during which each participant will have 3 visits (at month 0, month 1, andmonth 2).
DIETARY_SUPPLEMENT	Placebo	Dietary supplement: Placebo. The trial period of this study lasts for 2 months(8weeks), during which each participant will have 3 visits (at month 0, month 1, andmonth 2).

Timeline

• Start date: 2025-03-10
• Primary completion: 2025-09-30
• Completion: 2025-12-30
• First posted: 2025-03-20
• Last updated: 2025-03-20

Locations

1 site across 1 country: China